ttrna-xalt
Cell therapyexperimental
Clinical trial activity
5 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01326104)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ttrna-xalt
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06514898 | Phase 1 | Dec 31, 2024 | Georgetown University, University of Florida |
| NCT06254326 | Phase 1 | Sep 19, 2024 | University of Florida |
| NCT03396575 | Phase 1 | May 17, 2018 | University of Florida |
| NCT03334305 | Phase 1 | May 16, 2018 | National Cancer Institute (NCI), National Institutes of Health (NIH), National Pediatric Cancer Foundation, University of Florida, University of South Florida |
| NCT01326104 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2010 | Department of Defense, University of Florida |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Florida | Academic/Hospital | 5 | 5 | 2 | 2010 |
| Department of Defense | Government | 1 | 0 | 1 | 2010 |
| Georgetown University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2018 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2018 |
| National Pediatric Cancer Foundation | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of South Florida | Academic/Hospital | 1 | 0 | 1 | 2018 |
7 organizations
Page 1 / 1